Metrics of neonatal antibiotic use

Semin Perinatol. 2020 Dec;44(8):151329. doi: 10.1016/j.semperi.2020.151329. Epub 2020 Oct 13.


Responsible use of antibiotics is critical to preserve their effectiveness and to minimize adverse outcomes associated with overuse and misuse. Newborn infants are a unique population with high rates of antibiotic exposure. In order to improve neonatal antibiotic use, accurate and meaningful metrics are required. In this review, we highlight and compare existing antibiotic use metrics in detail, including definitions, current applications, advantages, and limitations of each metric, with a focus on applicability to neonatal populations. We explore future directions for identification of accurate and meaningful metrics that will allow hospitals and stakeholders to pinpoint antibiotic utilization practices that should be emulated or avoided, and ultimately improve the safety and quality of neonatal care.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Anti-Bacterial Agents* / adverse effects
  • Benchmarking*
  • Hospitals
  • Humans
  • Infant
  • Infant, Newborn


  • Anti-Bacterial Agents